Conflict of interest update
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is included in Acting Commissioner Lester Crawford's plans to help ensure avoidance of potential conflicts of interest. The agency will expand the number of its employees who are required to file financial holdings declarations; conduct an annual review linking outside activities to financial disclosure statements; release a "staff manual guide" on outside activities to help insure uniform practices; and develop a faster, electronic HHS Form 520, which is a "Request for Approval of Outside Activity" for both paid and unpaid work FDA employees perform outside of their official duties. The agency notes that in a review of 1,800 HHS Form 520s, it found no conflicts of interest. The House Energy & Commerce/Oversight & Investigations Subcommittee recently turned its attention to FDA after criticizing NIH for conflicts of interest (1"The Gray Sheet" May 24, 2004, p. 13)...
You may also be interested in...
FDA Ethics Under Spotlight Of House Oversight Subcommittee Investigation
The House Energy & Commerce/Oversight & Investigations Subcommittee is shifting its ongoing ethics investigation toward FDA, Rep. Joe Barton (R-Texas) said May 18 at an NIH ethics hearing
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.